vs

Side-by-side financial comparison of ACACIA RESEARCH CORP (ACTG) and HARROW, INC. (HROW). Click either name above to swap in a different company.

HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $50.1M, roughly 1.8× ACACIA RESEARCH CORP). HARROW, INC. runs the higher net margin — 7.4% vs 6.8%, a 0.6% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 2.6%). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 43.6%).

Acacia Research Corporation is a publicly traded American company based in New York City. It acquires and operates businesses in industries including the technology, energy, and industrial/manufacturing sectors. Acacia has a strategic relationship with Starboard Value, LP, the company's controlling shareholder. The company has been characterized as a patent troll.

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

ACTG vs HROW — Head-to-Head

Bigger by revenue
HROW
HROW
1.8× larger
HROW
$89.1M
$50.1M
ACTG
Growing faster (revenue YoY)
HROW
HROW
+30.7% gap
HROW
33.3%
2.6%
ACTG
Higher net margin
HROW
HROW
0.6% more per $
HROW
7.4%
6.8%
ACTG
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
43.6%
ACTG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACTG
ACTG
HROW
HROW
Revenue
$50.1M
$89.1M
Net Profit
$3.4M
$6.6M
Gross Margin
12.8%
79.3%
Operating Margin
-26.1%
17.5%
Net Margin
6.8%
7.4%
Revenue YoY
2.6%
33.3%
Net Profit YoY
125.5%
-2.2%
EPS (diluted)
$0.03
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACTG
ACTG
HROW
HROW
Q4 25
$50.1M
$89.1M
Q3 25
$59.4M
$71.6M
Q2 25
$51.2M
$63.7M
Q1 25
$124.4M
$47.8M
Q4 24
$48.8M
$66.8M
Q3 24
$23.3M
$49.3M
Q2 24
$25.8M
$48.9M
Q1 24
$24.3M
$34.6M
Net Profit
ACTG
ACTG
HROW
HROW
Q4 25
$3.4M
$6.6M
Q3 25
$-2.7M
$1.0M
Q2 25
$-3.3M
$5.0M
Q1 25
$24.3M
$-17.8M
Q4 24
$-13.4M
$6.8M
Q3 24
$-14.0M
$-4.2M
Q2 24
$-8.4M
$-6.5M
Q1 24
$-186.0K
$-13.6M
Gross Margin
ACTG
ACTG
HROW
HROW
Q4 25
12.8%
79.3%
Q3 25
21.2%
75.3%
Q2 25
12.8%
74.5%
Q1 25
47.4%
67.5%
Q4 24
17.6%
78.8%
Q3 24
10.1%
75.6%
Q2 24
26.2%
74.4%
Q1 24
49.2%
69.5%
Operating Margin
ACTG
ACTG
HROW
HROW
Q4 25
-26.1%
17.5%
Q3 25
-10.8%
20.6%
Q2 25
-24.2%
17.9%
Q1 25
30.8%
-23.5%
Q4 24
-32.4%
19.3%
Q3 24
-44.1%
2.7%
Q2 24
-18.4%
3.1%
Q1 24
-8.6%
-20.0%
Net Margin
ACTG
ACTG
HROW
HROW
Q4 25
6.8%
7.4%
Q3 25
-4.6%
1.4%
Q2 25
-6.4%
7.8%
Q1 25
19.5%
-37.2%
Q4 24
-27.5%
10.1%
Q3 24
-60.0%
-8.6%
Q2 24
-32.7%
-13.2%
Q1 24
-0.8%
-39.2%
EPS (diluted)
ACTG
ACTG
HROW
HROW
Q4 25
$0.03
$0.20
Q3 25
$-0.03
$0.03
Q2 25
$-0.03
$0.13
Q1 25
$0.25
$-0.50
Q4 24
$-0.14
$0.19
Q3 24
$-0.14
$-0.12
Q2 24
$-0.08
$-0.18
Q1 24
$0.00
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACTG
ACTG
HROW
HROW
Cash + ST InvestmentsLiquidity on hand
$306.7M
$72.9M
Total DebtLower is stronger
$91.9M
$250.0M
Stockholders' EquityBook value
$543.5M
$52.4M
Total Assets
$771.0M
$399.5M
Debt / EquityLower = less leverage
0.17×
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACTG
ACTG
HROW
HROW
Q4 25
$306.7M
$72.9M
Q3 25
$301.8M
$74.3M
Q2 25
$316.7M
$53.0M
Q1 25
$272.0M
$66.7M
Q4 24
$273.9M
$47.2M
Q3 24
$410.9M
$72.6M
Q2 24
$441.9M
$71.0M
Q1 24
$498.4M
$76.0M
Total Debt
ACTG
ACTG
HROW
HROW
Q4 25
$91.9M
$250.0M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
Q4 24
$262.7M
Q3 24
$230.7M
Q2 24
$236.3M
Q1 24
$243.4M
Stockholders' Equity
ACTG
ACTG
HROW
HROW
Q4 25
$543.5M
$52.4M
Q3 25
$537.6M
$47.0M
Q2 25
$538.6M
$49.7M
Q1 25
$540.2M
$56.5M
Q4 24
$514.8M
$69.7M
Q3 24
$540.2M
$58.0M
Q2 24
$560.7M
$58.5M
Q1 24
$568.3M
$60.6M
Total Assets
ACTG
ACTG
HROW
HROW
Q4 25
$771.0M
$399.5M
Q3 25
$768.9M
$363.1M
Q2 25
$775.5M
$345.0M
Q1 25
$801.6M
$364.2M
Q4 24
$756.4M
$389.0M
Q3 24
$707.6M
$351.5M
Q2 24
$753.6M
$306.6M
Q1 24
$631.7M
$295.5M
Debt / Equity
ACTG
ACTG
HROW
HROW
Q4 25
0.17×
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
Q3 24
3.98×
Q2 24
4.04×
Q1 24
4.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACTG
ACTG
HROW
HROW
Operating Cash FlowLast quarter
$75.2M
$8.4M
Free Cash FlowOCF − Capex
$8.1M
FCF MarginFCF / Revenue
9.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
22.01×
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACTG
ACTG
HROW
HROW
Q4 25
$75.2M
$8.4M
Q3 25
$9.5M
$16.6M
Q2 25
$50.1M
$-803.0K
Q1 25
$2.4M
$19.7M
Q4 24
$50.1M
$-17.8M
Q3 24
$-593.0K
$3.0M
Q2 24
$16.1M
$-2.7M
Q1 24
$54.8M
$-4.6M
Free Cash Flow
ACTG
ACTG
HROW
HROW
Q4 25
$8.1M
Q3 25
$16.4M
Q2 25
$-969.0K
Q1 25
$335.0K
$19.5M
Q4 24
$-98.5M
$-18.3M
Q3 24
$-2.8M
$2.3M
Q2 24
$-126.7M
$-3.1M
Q1 24
$54.6M
$-4.7M
FCF Margin
ACTG
ACTG
HROW
HROW
Q4 25
9.1%
Q3 25
22.9%
Q2 25
-1.5%
Q1 25
0.3%
40.8%
Q4 24
-201.8%
-27.4%
Q3 24
-12.1%
4.8%
Q2 24
-490.5%
-6.3%
Q1 24
224.4%
-13.6%
Capex Intensity
ACTG
ACTG
HROW
HROW
Q4 25
0.4%
Q3 25
0.3%
Q2 25
0.3%
Q1 25
1.7%
0.4%
Q4 24
304.4%
0.8%
Q3 24
9.6%
1.2%
Q2 24
553.0%
0.7%
Q1 24
1.1%
0.3%
Cash Conversion
ACTG
ACTG
HROW
HROW
Q4 25
22.01×
1.27×
Q3 25
16.26×
Q2 25
-0.16×
Q1 25
0.10×
Q4 24
-2.62×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACTG
ACTG

Energy Operations$16.0M32%
Transportation Safety$10.4M21%
Office Storage And Display Solutions$8.4M17%
Printers Consumables And Parts$6.5M13%
Natural Gas Reserves$5.1M10%
Natural Gas Liquids Reserves$3.3M7%

HROW
HROW

Segment breakdown not available.

Related Comparisons